HCA Healthcare, Inc. vs Pfizer, Inc. — Stock Comparison
HCA Healthcare, Inc. (HCA) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
HCA Healthcare, Inc. narrowly edges Pfizer, Inc. on Q·Score (6.5 vs 6.2 out of 10), led by Valuation (8.7 vs 7) and Sentiment (6.7 vs 5.2). Pfizer, Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for HCA (+31.9%) than for PFE (+11.4%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consensus analyst target of $510.95 is 32% above current price.
⚠ balance sheet warrants attention.
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
HCA vs PFE: which stock scores better overall?
Based on Q·Score, HCA Healthcare, Inc. (HCA) scores 6.5/10 versus Pfizer, Inc. (PFE) at 6.2/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: HCA or PFE?
HCA Healthcare, Inc. (HCA) scores higher on Growth (6.3/10 vs 5.1/10). HCA Healthcare, Inc. reports revenue growth (4.3% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is HCA or PFE more attractively valued?
HCA Healthcare, Inc. (HCA) scores higher on Valuation (8.7/10 vs 7/10). HCA trades at 11.7× P/E versus PFE at 9.2×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about HCA vs PFE?
There are 21 analysts covering HCA with a consensus price target of $510.95, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: HCA or PFE?
Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 5.8/10). Net profit margin: HCA at 8.9%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: HCA or PFE?
Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 5.4/10). Market beta: HCA at 1.19, PFE at 0.30. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of HCA and PFE?
HCA Healthcare, Inc. (HCA) has a market capitalisation of $86.0B, while Pfizer, Inc. (PFE) has a market cap of $149.3B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do HCA or PFE pay dividends?
HCA pays a dividend yield of 0.80%, while PFE pays a dividend yield of 6.56%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →